Archive for author Simon Wentworth

2016 Life Sciences Industry: Year in Review

Mergers and acquisitions Notwithstanding a fair degree of economic and political uncertainty, M&A activity in the global life sciences industry remains buoyant. The year got off to a strong start with over $30bn of deals in Q1 and $80bn in Q2. Deals worth over $45bn were closed in ...

Coming Soon — Embed Animations With The Video Control

We’re pleased to announce the imminent launch of the Video control, a powerful new tool for app developers using BaseCase Interactive. The Video control makes it possible to create more dynamic, visually expressive and interactive tools for customer engagement. Video playback in a BaseCase app has until now been ac...

How to convert PDFs into interactive apps

How can you convert your PDFs into dynamic apps for customer engagement? A new, user-friendly feature on BaseCase Interactive helps you do this with just a few clicks. It doesn’t matter what device your team prefers - iPad, laptop, Microsoft Surface or Android tablets - your newly interactive presentations wi...

Using RWD Tip #6 — Keep it simple and transparent

To present a credible value story, it’s essential to maintain transparency. If you’re using large datasets and novel sources of evidence, it’s even more important to offer clients easy access to your sources. When integrating real-world data into customer-facing tools, be sure to show, share and reference new da...

Dodgy Wi-Fi? Make sure your digital tools work offline

Traditionally, access to dynamic information such as real-world datasets has been provided via a central data repository referenced over the internet. However, it’s not always possible to guarantee a reliable internet connection in the field. Securing a meeting with an important payer or healthcare provider only to find that yo...

Using RWD: Tip #5 — Get a better MLR approval process

Market access professionals know all too well that the medical, legal and regulatory review process can be challenging to manage, and time-consuming to execute. However, with a modern MLR approval process it’s possible to use large real-world datasets in your customer engagement tools without causing extra delay. Part of th...

Localize real-world data to boost customer engagement

Real-world data is powerful partly because it can help communicate the potential impact of a new drug or medical device, not just in trials, but in the ‘real world’. But it’s important to appreciate how much ‘real world’ settings can differ between markets, products and regions - there is no single ...

What kinds of RWD can you use in a customer engagement tool?

Clever use of real-world data does not require supercomputers to crunch ‘big data’. We recommend identifying data sources early - perhaps as an extension of building a value dossier - and then incorporating that data into field-based applications. Useful sources to consider include: patient population data, prescribing information, pricing information, regi...

Get easy-to-update digital tools that integrate RWD

The market access landscape is constantly changing, and real-world data starts going out-of-date the moment it’s published. For it to deliver a meaningful edge in the field, RWD must be incorporated into your digital tools rapidly. One thing we learned in our discussions with clients and industry experts is th...

Avoid compliance problems using RWD in the field

Compliance is already the one thing most likely to keep market access professionals awake at night. As large real-world datasets start to become more important, the challenges of keeping on top of the evidence and staying compliant threaten to undermine sleep even further. Fortunately, there is a way to streamline ...

How to use real-world data to monitor competitive threats

In a dynamic and highly competitive market, two things are important: monitoring trends effectively, and having the capability to react fast. Real-world data can provide actionable insights into market developments. Commercial managers can use RWD to update internal audiences on market share, competitive threats from new efficacy data, or pricing ...

Can you afford not to use RWD in your tools?

At a time of rising costs, the thought of integrating large datasets into your customer engagement tools can seem daunting - but it needn’t be expensive, or time-consuming. ‘Big data’ is now used across the life science industries, for a range of purposes. It’s used to develop new drugs an...

Top five benefits of Sofware‑as‑a‑Service

The much talked about benefits of the Software-as-a-Service (SaaS) model are fueling widespread adoption of Cloud-computing products in the life sciences industry. But how does it work exactly? And what advantages are there? Traditionally, clients purchase a software product from a vendor and install it on their systems. They then ...

Meet us at ISPOR Singapore

ISPOR SINGAPORE, September — We’re looking forward to meeting our clients in the Asia-Pacific area at ISPOR’s seventh annual conference in the region. Stop by table 5 for an informal demo of the latest features and updates to our customer engagement technology. To arrange a meeting in advance, please email cont...

BaseCase Berlin HQ to double in size

It’s been two years since BaseCase moved to a new and much larger HQ, close to the historic Checkpoint Charlie in Berlin. In that time we’ve continued to experience tremendous growth, with constantly increasing levels of interest in our customer engagement technology from clients in the areas of mark...

Three key goals for pharma customer engagement

(1) 360° Integration The benefits of integration are obvious. When systems talk the same language they can operate faster and deliver synergies across different parts of the business. Leading technologist Hank Summy notes that: ‘Integration is key. The solutions that are able to unify data, analytics, workflows, and content…are the ones tha...

June Events — Minneapolis and London

MedForce Summit, 6-8 June, Minneapolis The MedForce Summit boasts an impressive lineup of speakers and industry experts, and a highly relevant list of topics. With years of experience in the medical device and diagnostics sector, BaseCase is happy to support the event, and we’d love to meet you there. BO...

Measuring the impact of malaria

Evidence from mosquitoes found trapped in amber tells us that malaria has existed for at least 30 million years. Human settlement and population levels were affected by the disease in the Neolithic era, and several disorders such as sickle-cell anemia and thalassemia are known to have evolved as a result of ...

Pfizer drops $160b Allergan deal

Pfizer has walked away from its record-breaking $160 billion deal with Allergan. The decision comes just days after action from the US Treasury to make such tax-inversion deals less attractive, a move widely believed to have been taken in direct response to the pharma giant’s headline-grabbing announcement. Under the planned ch...

$1.8b Novo Nordisk facility sign of growing diabetes market

Novo Nordisk has announced it will spend $1.8 billion on a new facility to produce active pharmaceutical ingredients (APIs) for its current and future insulin and GLP-1 medicines. The plant will cover an area the size of seven football pitches, and will be built next to an existing site, roughly half ...

'Brexit' spells years of chaos for UK pharma industry

Calling for an in-out referendum on the UK’s EU membership, Prime Minister David Cameron spoke of a ‘…crisis of European competitiveness, as other nations across the world soar ahead’. He also described ‘excessive regulation’ on business as a ‘self-inflicted wound’. Now, as the UK contemplates so-called Brexit, pharma and medical device...

Pfizer buys Allergan for $160 billion

The biggest pharmaceuticals deal in history is set to go ahead, as Pfizer announces the completion of its much-anticipated $160 billion agreement with Dublin-based Allergan Plc. Pfizer CEO Ian Read, who will become chief executive and chairman of the new business, commented that: The proposed combination of Pfizer and Allergan will ...

Medical Device Access Leaders Forum 2015

We’re attending NextLevel’s Medical Device Access Leaders Forum in Berlin, 8 - 10 December. Meet us at the event to learn how to: Rapidly develop customer engagement apps for the iPad - in-house, without using programming. Visualize the full economic value of your products with ROI calculators, budget impact tools and ...

New diagnostic techniques promise better cancer treatment

A medium-sized revolution is underway in the tumor profiling market, propelling point-of-care diagnostics, cost-effective treatment options, and personalized medicine to the fore. The implications for the major medical device and diagnostics players are considerable. As the below graph indicates, the value of this market is expected to increase from $13 billion ...

Bulk operations make life easier for admins

Last week we added some time-saving features to the platform that are of particular interest to BaseCase users with responsibility for administering user accounts. ‘Bulk operations’ enable you to apply changes to a large number of accounts at the same time, rather than one by one. If you’re an admin ...

Pharma outlook: pricing and market access

We’ve remarked previously that the general outlook for the life sciences industry in the coming period is positive, and the below forecast from a Deloitte report supports that view. This outlook is based partly on the observation that: “…improving R&D productivity, recent increases in NME approvals, and expa...

Teva buys part of Allergan for $40b. What future for generics?

To the surprise of many, Teva has moved quickly to snap up Allergan’s generics business for around $34 billion in cash and $7 billion in shares. The deal has already been approved by the boards of both companies, and will not require any shareholder vote to take place. The transaction is ex...

The Key to Success with Closed Loop Marketing

Read the full article There is a lot of buzz in the life sciences about Closed Loop Marketing (CLM). Content distribution companies increasingly market their products around this concept, which promise to some degree the ability to collect data from client interactions and respond to it. The most important element ...

Health Economics and Outcomes Research – What's the Value?

In order to gain market access and remain competitive, pharmaceutical and medical technology manufacturers must be able to demonstrate clinical and economic evidence to providers, healthcare decision-makers and payers. Now more than ever, pricing pressure and regulatory restrictions are generating increased demand for this kind of outcomes evidence. Kevin Mayo, ...

New report tracks U.S. pivot from prescriber to payer

For several years we’ve noted the rising importance of payers and a marked shift in focus away from prescribers. In a new report*, industry analysts detail further entrenchment of this trend in North America, as new pharmaceutical products and medical devices receive heightened attention in respect of their cost-saving at...

Ageing population demands oncology, med device products

The market for age-related treatments is buoyant, as technological advancements across the life sciences industry continue to help older people lead healthier, longer lives. As well as more and better treatments, there are also steadily more people entering the 65+ demographic. In the US and the west, this is partly due ...

Popups: new and improved!

After several months of planning and implementation, we’re very pleased to announce the release of the new-style popup on BaseCase Interactive. The new popup represents a real leap forward from the version it replaces. With enhanced styling options, you can create a diverse range of sophisticated designs that cohere wi...

BaseCase apps now faster and more powerful

Since we rebuilt the spreadsheet editor in 2013, our customers have benefited from a faster, better performing platform that can handle larger spreadsheet models. We’ve also been working on improving the processing speed of the platform, and today we’re ready to announce a substantial improvement in app performance. The impr...

$3.5 billion market for advanced wound care

By 2021, the worldwide market for advanced wound dressings will exceed $3.5 billion, according to a new analysis* of global medical device market trends. While the major medical device manufacturers continue to dominate, smaller players such as Acelity, Paul Hartmann and Urgo are making significant inroads. The big hitters they’re up ag...

9 tips to get the most out of BaseCase Interactive

I spend much of my time talking about the main features and benefits of BaseCase Interactive - in a nutshell, the fact that it helps market access teams improve value communication while saving time and money. This remains our core value proposition, but there are also a large number of ...

China pharma market boom

By 2020, pharmaceutical sales in China will top $300 billion, making it the second largest pharma market in the world. That represents a six-fold increase from 2012 - an astonishing compound annual growth rate of 26.5%. Population growth and demographic changes are partly responsible, say analysts GlobalData. Another significant factor is regulatory reform. A ...

½ trillion dollar pharma market by 2020

The recent surge in new drug approvals is one reason why the US market in pharmaceuticals could be worth over $500 billion by 2020, according to a new report from GlobalData. The increase in value represents a formidable compound annual growth rate of 5.6%. Other mature markets are set to grow much more ...

Interview: Nicolas Hatcher, Software Developer at BaseCase

Nicolas Hatcher moved Berlin after more than a decade teaching theoretical physics at the University of Simon Bolivar, Caracas. We spoke about his role as a software developer and what it’s like working for BaseCase. What does BaseCase build? Our main product is a web application that our customers ...

Interview: Devendra Gera, Lead Infrastructure Engineer

Devendra Gera joined BaseCase as a software developer and later became Lead Infrastructure Engineer. We spoke about his role at at BaseCase, and the challenges of building powerful software that anyone can use. What does BaseCase build? BaseCase Interactive can be thought of as a combination of Excel, PowerPoint, a ...

PDF reports now include dynamic references

To maintain transparency and present a credible value story, it’s important to offer easy access to your sources. That’s why earlier updates to the platform have included reference management, reference styling and reference lists. Our latest release builds on this suite of features by making it easier to incl...

Enhance confidentiality with the signature control

In the life sciences industry, confidentiality and data security are of the utmost importance, and it’s often desirable to ask users to accept a disclaimer, terms of use or confidentiality statement. The new signature control further bolsters security, by enabling you to take a signature during a presentation. The us...

Dynamic storyboard: more flexible, tailored presentations

One of the key principles of effective value communication is the importance of a lean, highly-tailored value story. Clients are busy, and it’s essential not to dilute the core value proposition with information that is less relevant for them. The new dynamic storyboard was created with this principle in mi...

Copy and paste now available in BaseCase Interactive

We’ve added the familiar copy-paste operation to BaseCase Interactive, providing new capabilities and helping you to save time when developing a presentation. If you’re building an app on a Windows machine, use ‘Ctrl+C’ to copy, and ‘Ctrl+V’ to paste. For Mac users, it’s ‘Cmd+C’ and ‘C...

New example: interactive iPad app for the sales force

Last week we created a new example app for our online Gallery, typical of the kind of sales tool or e-detailing app built by our clients in the pharmaceutical industry. Here’s what we designed: Fingaxil core app, English iPad presentation to be used by sales reps in meetings with he...

What impact has the Sunshine Act had?

Last August the Open Payments system turned one, and the first batch of data was released by the US Centers for Medicare and Medicaid Services (CMS) shortly thereafter. What has the impact been, and were there any surprises? The Physician Payment Sunshine Act was a key plank of Barack Obama’s ...

18-year high for new drug approvals

Not since 1996 has the FDA approved so many new medicines - 41 last year including four for AstraZeneca and three each for Biogen Idec, Eli Lilly and Merck & Co. In Europe, the market for new drugs is similarly dynamic, with the European Medicines Agency approving 83 new medications in 2014. This number, ...

Shire buys NPS Pharmaceuticals for $5.2 billion

Shire Plc has strengthened its position in the important growth area of biopharmaceuticals by acquiring its U.S. rival NPS Pharma. Chief executive Flemming Ornskov described the move as “…a significant step in advancing Shire’s strategy to become a leading biotechnology company”. On the rebound following its recent jilting by A...

Pharma industry outlook for 2015

Despite economic pressures in healthcare markets and the wider global economy, the resilience shown by the pharmaceutical industry looks set to carry on through 2015. A recent report from Thomson Reuters indicates that global pharmaceutical sales topped $1 trillion last year, following the high-water mark of $980 billion recorded the year before, and ...

New USA Map for visualizing data and selecting states

This year we’re extending our range of map controls, and the latest addition is the new USA Map. It’s the second in the series to be released, following the Europe Map, and it has the same full range of functions and styling options. As the below example shows, the ...

Every country counts: engage payers in all your markets

Pharma and medical device markets vary widely in size: there’s a handful of big fish, a haul of medium-sized opportunities and a lot of minnows. The uneven nature of the global marketplace can create an investment imbalance. When launching a new product, the obvious areas of focus for marketing an...

Create cleaner, more interactive apps with the Dynamic box

Use the datafeed to determine which panel to show The new Dynamic box control has a wide range of applications that help you to create cleaner, more dynamic and interactive value stories. It works just like a Basic box, but with multiple panels, so you can change the content of ...

BaseCase adds support for Excel array formulas

Over the last several months, we’ve been working hard to implement array formulas on the BaseCase Editor, and we’re now proud to announce the successful completion of the project. Led by Senior Software Developer Nicolas Hatcher, the successful integration of array formulas represents a significant milestone that improves Base...

Happy Holidays from BaseCase

2014 was another year of extraordinary growth, and we’d like to thank all of our clients and colleagues for making that possible. As this year’s greetings card shows, BaseCase is now a truly global company, with new talent from South America, India and the U.S. joining the team in t...

Leverage your evidence to promote market adoption

As the results of Novartis’ clinical trial of heart drug LCZ696 were published, we witnessed a striking demonstration of the value of good clinical data. Shares jumped in price by several percentage points, instantly adding billions to the value of the company. In comparison with the standard treatment, Novartis’ compound was ...

Interview: Nikolaos Tsitiridis, Value Communication Expert

First of all, thanks for taking the time to talk to us. Can you say a little about your background? Thank you for having me. I’m originally from Greece. I did my bachelor’s in economics there, and then my master’s in health economics in the Netherlands. I worked...

For your next product launch, engage payers better

Start right away with our app development team Whatever the long-term strategy, the most urgent and pressing requirements always stem from the product launch that is just around the corner. We’ve found that new business relationships tend to begin because there is a particular project underway, and the client re...

Helping Global Players Reach Local Payers

Markets Without Borders An increasingly challenging legislative environment and competitors entering the market with alternative brands or generics are two of the factors currently holding the attention of global pharma companies. In the US alone, patent protections covering branded pharmaceuticals worth over US$100 billion annually are about to expire, increasing ...

Value communication updates

It’s nearly a year since the last European Congress of ISPOR, and since then our product development team have been focused on a number of key platform improvements. At this year’s event, we’re ready to unveil a host of updates and new design features that make it easier...

New features to improve navigation

We’re very pleased to announce the new Navigation List control and the Navigation Popover. These new features were designed by our Director of Product Design Jeff Nichols to help you provide a clear navigation experience for your users. Navigation List control A Navigation List is a vertical panel, normally po...

Localize your apps with the Currency Selector

Currency Selector example In this example app, a Currency Selector is used to define which currency is displayed in a Table and a Text Field Our multinational clients often want to roll out apps for use in different countries. The Currency Selector allows them to create more flexible apps that ...

Do you experience a Global-Local disconnect?

As market access rises in importance, attempts to improve payer engagement across the business may bring into sharp relief an old struggle: the Global-Local disconnect. For a multinational enterprise, the challenges of communicating between countries and across different parts of the business are far from trivial. Aligning goals and meeting ...

The Top Do's and Don'ts of Value Communication

When your scientific and economic data is complex, the need to extract and communicate a clear value message is more important than ever. These key recommendations will help to ensure you communicate the economic and clinical value of your products in a way your target audience will understand and trust. ...

E-Detailing on the iPad: the essential sales tool

When the iPad hit the market in 2010, no one was sure how this new product would impact on business. But fast forward two years and the iPad has found an application in almost every industry. This includes healthcare, with major developments in m-health and e-health attributed to the ‘iPad revolution’. ...

Budget impact models - making an impact

Budget impact models (BIMs) are increasingly being used to determine the financial impact of new products on the budgets of healthcare decision-makers across the globe. In periods of financial pressure, stakeholders are highly cost conscious, leaving pharmaceutical, medical device and diagnostic firms struggling with ways to clearly present the real ...

New HQ for growing BaseCase team

We’ve changed headquarters to accommodate a rapidly growing team of software developers, consultants and health economists here at BaseCase. Since 2007, BaseCase products have improved customer engagement for market access teams throughout Europe and North America. We’ve always been based in Berlin, but as the company has grown we’ve had...

New reference styling makes it easy to show your payers the evidence

When making a presentation based around health economic evidence, it’s important to ensure that the payers and healthcare professionals you meet with have easy access to the underlying research. The aim is to inspire confidence and maintain credibility. That’s why we integrated reference management into the platform. References are ...

Interview with Katrin Yr Magnusdottir, Roche Denmark

Katrin Yr Magnusdottir, Roche Denmark First of all, thanks for taking the time to talk to us. You are the Pricing and Tender manager at Roche Denmark, is that right? That’s right. I’m responsible for pricing and tender management and I’m involved in health economics and market access...

Discover BaseCase at ISPOR Montreal 2014

This year the International Congress of ISPOR is taking place in Montreal, from 31st May to 4th June. It’s the industry’s leading conference for the HEOR community, and we are pleased to be one of the sponsors at the event. Throughout the congress, BaseCase CTO Diarmuid Glynn will be j...

What are your global app development costs?

The costs of developing apps for market access are fragmented and spread out across country affiliates. As a result, it’s hard to see how it adds up, and often no one appreciates how much is being spent. When you factor in the expense of localizing and maintaining apps, the ...

Wider range of fonts now available

We’ve added a range of new fonts to the app editor in BaseCase Interactive, providing greater flexibility in the design of apps. It will also enable you to better match the look of your target platform (e.g. using Helvetica Neue for the iPad, since that is the default fo...

Over 50 new functions added to the BaseCase Editor

We’ve just added more than fifty new functions to the BaseCase Editor. These include math, information, logical and statistical functions. We’re continually increasing the number of functions that we support, to extend the functionality of the editor and enable you to create more powerful apps. As a result, it’s...

New color picker enables layer effects

We’ve created a new color picker with more advanced options. With the new color picker, there are a wider range of colors to choose from, and you can view the ‘current’ and ‘new’ selection side by side for ease of comparison. *Current* and *New* selection comparison The tool also includes a...

Cut costs with a new translation workflow

Global market access managers often face challenges translating their customer engagement apps into different languages. Working with external vendors is both costly and time-consuming. With BaseCase Interactive it’s much simpler. And now our development team have released a new feature that makes the process even easier. The localization tool ...

Value Communications v2.0: Getting the Foundations Right

In this guest article by Richard Mee and Andrew Hobbs from BaseCase partner Pope Woodhead, the authors explore the essential foundations needed for success – and define the leadership role now required from health economics and market access. Pope Woodhead is a multi-disciplinary consultancy based in Cambridge, UK with specific expertise in...

Sales and Marketing Strategies in the Pharmaceutical Industry

The impact of legislative changes, economic turmoil and an increase in competition from generics and biosimilars is forcing change in the pharmaceutical industry. In an increasingly crowded marketplace, there is pressure to ensure that sales force effectiveness is maximized, and the correct sales and marketing strategy implemented. The success factors ...

Access the Brazilian market

In Brazil, the market for pharmaceuticals is worth US$35 billion and is expected to be the third largest in the world by 2020, after the U.S. and China. Total healthcare expenditure already exceeds US$220 billion, and there is a growing private market - a quarter of the country’s 200 million pe...

Three ways pharma can make market access count

Traditionally, engagement with payers and healthcare providers has been about providing information on the safety and clinical efficacy of a drug or medical device. This remains as important as ever, but payers have become more cost-conscious and market access teams are now also tasked with demonstrating economic value. As the ...

Cloud Computing and e-Detailing on the iPad

Pharmaceutical companies’ use of mobile sales tools to increase sales effectiveness The wild success of Apple’s fifth generation tablet device - the iPad Mini – seems predictable, even inevitable. Easy to forget that less than a few years ago, tablet computing was untested and sometimes controversial, in the wider marketplace as...

Closed Loop Marketing: Closing the Gap for Pharma

Although the concept of Closed Loop Marketing (CLM) has been around in the pharmaceutical industry for years, renewed attention is being generated by the development of new e-detailing technologies that act as a catalyst to the marketing cycle. Feedback + Analytics = Growth Jim Sale of IMS Health defines CLM as “a ...

Closed Loop Marketing for market access

About Closed Loop Marketing As a manager working in market access or HEOR, you may not have heard about Closed Loop Marketing. Closed Loop Marketing software is being used by most pharma companies, but to date it has only been used to support the pharma sales force in their engagement ...

BaseCase Versus Custom-Built Apps

The benefits of using the BaseCase platform to build value communication apps BaseCase is a web-based platform that lets pharma and medical device companies build their own apps for key account managers. It’s a global solution to the ongoing need for value communication tools, designed to replace the per ...

Pharmaceutical Data Security: Controlling the Message

There are a number of reasons for pharma companies to be very interested in retaining control over the kinds of messages that are sent out to payers and healthcare providers in various markets. A well managed market access and marketing strategy can create a competitive advantage. On the other hand, ...

Access to Medicines: The Role of Pricing and Technology

In this guest article, Rochelle Sampy from eyeforpharma speaks to Richard Bergström, Director General of the EFPIA about equal access to medicines, pricing disparities across the EU and the role technology can play in bringing affordable healthcare to millions. The pharmaceutical industry is constantly engaged with national governments and o...

Changing Value in America: Obamacare and Market Access

CNN recently aired the documentary film Escape Fire, a homily on the American healthcare system. The crux of the argument is that healthcare in the US has a dysfunctional pricing structure. To cut costs and improve care, value ought to be placed more on outcomes and less on treatments. Stakeholders ...

Success Factors in Value Communication Design - Layering Information

This is Part 3 of the ‘Success Factors in Value Communication Design’ series, a set of articles that examine the key success factors in creating customer engagement tools that successfully communicate the clinical and economic benefits of pharmaceuticals, devices and diagnostics. These recommendations have been drawn from the experiences of Gijs ...

How to roll out a global value proposition to local affiliates

Over the last several years pharma sales and marketing strategy has changed, moving towards HEOR-based engagement with payers and providers rather than traditional prescriber marketing. This is due to a diverse range of factors, including economic constraints and a changing legislative environment in the U.S. and worldwide. The renewed ...

Berlin

BaseCase Management GmbH
Charlottenstr. 16 10117
Berlin, Germany

Phone +49 30 2014 364 0
Fax +49 30 577 05 67 19
Email info@basecase.com

USt-ID (VAT) DE269455992

New York

BaseCase, Inc.
41 East 11th Street, 11th Floor
New York, NY 10003